Lewis P Amsel

Title: Lewis P Amsel: Innovator in ADHD Treatment

Introduction

Lewis P Amsel is a notable inventor based in Sarasota, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of attention deficit/hyperactivity disorder (ADHD). His innovative work has the potential to improve the lives of many individuals affected by this condition.

Latest Patents

Amsel holds a patent for the "Mazindol IR/SR multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (ADHD)." This invention relates to a modified-release composition of mazindol, which is utilized in treating attention deficit disorders (ADD) or ADHD. The patent addresses related issues such as incoercible sleepiness, decline of vigilance, and excessive daytime sleepiness, particularly in children, adolescents, and adults.

Career Highlights

Lewis P Amsel has been associated with NLS Pharmaceutics AG, where he has played a crucial role in developing innovative pharmaceutical solutions. His work focuses on enhancing the efficacy of treatments for ADHD, showcasing his commitment to improving patient outcomes.

Collaborations

Amsel has collaborated with notable colleagues, including Alexander C Zwyer and Virginia Schmith. These partnerships have contributed to the advancement of research and development in the pharmaceutical industry.

Conclusion

Lewis P Amsel's contributions to ADHD treatment through his patented invention highlight his dedication to innovation in the pharmaceutical field. His work continues to pave the way for improved therapeutic options for individuals affected by attention deficit disorders.